Table 2 Open in new tab Treatment... | Oxford Academic

Table 2

Open in new tab

Treatment failure in 18 study subjects

Patient #	Molecular Subgroup	Histology	WHO Grade	Extent of Tumor Resection Prior to RT	Gain of 1q at Diagnosis	Site of recurrence or Progressive Disease	Time to Treatment Failure, years	Time from Treatment Failure to Last Follow-Up, years	Survival Status
1	PF-EPN-A	Anaplastic	III	GTR	No	Local	0.14	4.84	Dead
2	PF-EPN-A	Anaplastic	III	GTR	Yes	Distant	5.42	3.13	Dead
3	PF-EPN-A	Anaplastic	III	GTR	No	Local	5.97	0.97	Dead
4	PF-EPN-A	Classic	II	STR	No	Distant	1.10	2.03	Dead
5	PF-EPN-A	Classic	II	GTR	No	Distant	7.26	1.35	Alive
6	PF-EPN-A	Anaplastic	III	GTR	No	Combined	3.66	0.07	Dead
7	PF-EPN-A	Classic	II	STR	No	Local	4.75	0.94	Alive
8	PF-EPN-A	Anaplastic	III	GTR	Yes	Local	4.15	2.89	Alive
9	ST-EPN-RELA	Anaplastic	III	NTR	Not applicable	Distant	2.38	4.67	Dead
10	PF-EPN-A	Classic	II	GTR	No	Distant	2.12	0.89	Alive
11	PF-EPN-A	Classic	II	GTR	No	Local	0.14	0.08	Alive
12	PF-EPN-A	Anaplastic	III	GTR	No	Local	0.18	3.87	Alive
13	PF-EPN-A	Anaplastic	III	STR	No	Distant	2.27	5.75	Alive
14	PF-EPN-A	Classic	II	GTR	No	Local	3.28	1.27	Dead
15	PF-EPN-A	Anaplastic	III	STR	Yes	Distant	1.85	0.33	Dead
16	PF-EPN-A	Anaplastic	III	GTR	Yes	Local	1.01	3.05	Alive
17	PF-EPN-A	Anaplastic	III	GTR	No	Distant	6.56	0.3	Alive
18	PF-EPN-A	Anaplastic	III	NTR	No	Distant	1.81	0.25	Alive

Patient #	Molecular Subgroup	Histology	WHO Grade	Extent of Tumor Resection Prior to RT	Gain of 1q at Diagnosis	Site of recurrence or Progressive Disease	Time to Treatment Failure, years	Time from Treatment Failure to Last Follow-Up, years	Survival Status
1	PF-EPN-A	Anaplastic	III	GTR	No	Local	0.14	4.84	Dead
2	PF-EPN-A	Anaplastic	III	GTR	Yes	Distant	5.42	3.13	Dead
3	PF-EPN-A	Anaplastic	III	GTR	No	Local	5.97	0.97	Dead
4	PF-EPN-A	Classic	II	STR	No	Distant	1.10	2.03	Dead
5	PF-EPN-A	Classic	II	GTR	No	Distant	7.26	1.35	Alive
6	PF-EPN-A	Anaplastic	III	GTR	No	Combined	3.66	0.07	Dead
7	PF-EPN-A	Classic	II	STR	No	Local	4.75	0.94	Alive
8	PF-EPN-A	Anaplastic	III	GTR	Yes	Local	4.15	2.89	Alive
9	ST-EPN-RELA	Anaplastic	III	NTR	Not applicable	Distant	2.38	4.67	Dead
10	PF-EPN-A	Classic	II	GTR	No	Distant	2.12	0.89	Alive
11	PF-EPN-A	Classic	II	GTR	No	Local	0.14	0.08	Alive
12	PF-EPN-A	Anaplastic	III	GTR	No	Local	0.18	3.87	Alive
13	PF-EPN-A	Anaplastic	III	STR	No	Distant	2.27	5.75	Alive
14	PF-EPN-A	Classic	II	GTR	No	Local	3.28	1.27	Dead
15	PF-EPN-A	Anaplastic	III	STR	Yes	Distant	1.85	0.33	Dead
16	PF-EPN-A	Anaplastic	III	GTR	Yes	Local	1.01	3.05	Alive
17	PF-EPN-A	Anaplastic	III	GTR	No	Distant	6.56	0.3	Alive
18	PF-EPN-A	Anaplastic	III	NTR	No	Distant	1.81	0.25	Alive

Table 2

Open in new tab

Treatment failure in 18 study subjects

Patient #	Molecular Subgroup	Histology	WHO Grade	Extent of Tumor Resection Prior to RT	Gain of 1q at Diagnosis	Site of recurrence or Progressive Disease	Time to Treatment Failure, years	Time from Treatment Failure to Last Follow-Up, years	Survival Status
1	PF-EPN-A	Anaplastic	III	GTR	No	Local	0.14	4.84	Dead
2	PF-EPN-A	Anaplastic	III	GTR	Yes	Distant	5.42	3.13	Dead
3	PF-EPN-A	Anaplastic	III	GTR	No	Local	5.97	0.97	Dead
4	PF-EPN-A	Classic	II	STR	No	Distant	1.10	2.03	Dead
5	PF-EPN-A	Classic	II	GTR	No	Distant	7.26	1.35	Alive
6	PF-EPN-A	Anaplastic	III	GTR	No	Combined	3.66	0.07	Dead
7	PF-EPN-A	Classic	II	STR	No	Local	4.75	0.94	Alive
8	PF-EPN-A	Anaplastic	III	GTR	Yes	Local	4.15	2.89	Alive
9	ST-EPN-RELA	Anaplastic	III	NTR	Not applicable	Distant	2.38	4.67	Dead
10	PF-EPN-A	Classic	II	GTR	No	Distant	2.12	0.89	Alive
11	PF-EPN-A	Classic	II	GTR	No	Local	0.14	0.08	Alive
12	PF-EPN-A	Anaplastic	III	GTR	No	Local	0.18	3.87	Alive
13	PF-EPN-A	Anaplastic	III	STR	No	Distant	2.27	5.75	Alive
14	PF-EPN-A	Classic	II	GTR	No	Local	3.28	1.27	Dead
15	PF-EPN-A	Anaplastic	III	STR	Yes	Distant	1.85	0.33	Dead
16	PF-EPN-A	Anaplastic	III	GTR	Yes	Local	1.01	3.05	Alive
17	PF-EPN-A	Anaplastic	III	GTR	No	Distant	6.56	0.3	Alive
18	PF-EPN-A	Anaplastic	III	NTR	No	Distant	1.81	0.25	Alive

Patient #	Molecular Subgroup	Histology	WHO Grade	Extent of Tumor Resection Prior to RT	Gain of 1q at Diagnosis	Site of recurrence or Progressive Disease	Time to Treatment Failure, years	Time from Treatment Failure to Last Follow-Up, years	Survival Status
1	PF-EPN-A	Anaplastic	III	GTR	No	Local	0.14	4.84	Dead
2	PF-EPN-A	Anaplastic	III	GTR	Yes	Distant	5.42	3.13	Dead
3	PF-EPN-A	Anaplastic	III	GTR	No	Local	5.97	0.97	Dead
4	PF-EPN-A	Classic	II	STR	No	Distant	1.10	2.03	Dead
5	PF-EPN-A	Classic	II	GTR	No	Distant	7.26	1.35	Alive
6	PF-EPN-A	Anaplastic	III	GTR	No	Combined	3.66	0.07	Dead
7	PF-EPN-A	Classic	II	STR	No	Local	4.75	0.94	Alive
8	PF-EPN-A	Anaplastic	III	GTR	Yes	Local	4.15	2.89	Alive
9	ST-EPN-RELA	Anaplastic	III	NTR	Not applicable	Distant	2.38	4.67	Dead
10	PF-EPN-A	Classic	II	GTR	No	Distant	2.12	0.89	Alive
11	PF-EPN-A	Classic	II	GTR	No	Local	0.14	0.08	Alive
12	PF-EPN-A	Anaplastic	III	GTR	No	Local	0.18	3.87	Alive
13	PF-EPN-A	Anaplastic	III	STR	No	Distant	2.27	5.75	Alive
14	PF-EPN-A	Classic	II	GTR	No	Local	3.28	1.27	Dead
15	PF-EPN-A	Anaplastic	III	STR	Yes	Distant	1.85	0.33	Dead
16	PF-EPN-A	Anaplastic	III	GTR	Yes	Local	1.01	3.05	Alive
17	PF-EPN-A	Anaplastic	III	GTR	No	Distant	6.56	0.3	Alive
18	PF-EPN-A	Anaplastic	III	NTR	No	Distant	1.81	0.25	Alive